English
Polski
Español
українська
The most important advances in hematology
If you were to name the 3 most important recent advances in hematology that are relevant for everyday practice, what would they be?
2023-03-23
If you were to name the 3 most important recent advances in hematology that are relevant for everyday practice, what would they be?
Dr Mark Crowther from McMaster University shares his views on the 3 most important recent advances in the management of nonmalignant blood diseases.
What is your management of secondary thrombocytosis?
Do you perform cytogenetic tests in every patient with a myeloproliferative neoplasm (MPN)?
Do you treat low-risk asymptomatic patients with primary myelofibrosis (PMF)?
How do you reduce the risk of infection in patients treated with ruxolitinib?
Are there any patients with essential thrombocythemia (ET) or polycythemia vera (PV) who do not need antiplatelet treatment?
How to manage patients with secondary polycythemia? Should we perform phlebotomies or administer antiplatelet treatment?
Which cytoreductive drug is your first-line option for the treatment of myeloproliferative neoplasms (MNPs)?
